Trump's Big Week: Middle East Trip, China Deal, Pharma EO, "Big, Beautiful Bill" with Ben Shapiro
Trump's Big Week: Middle East Trip, China Deal, Pharma EO, "Big, Beautiful Bill" with Ben Shapiro
Trump's Big Week: Middle East Trip, China Deal, Pharma EO, "Big, Beautiful Bill" with Ben Shapiro
In this episode, the hosts delve into a range of political and economic topics with guest Ben Shapiro. Discussions include Trump's Middle East trip, its economic outcomes, and implications for US foreign policy. The podcast also examines trade relations between the US and China, fiscal challenges facing the GOP, and controversies surrounding bans on cell-based meat.
The podcast explores significant geopolitical and economic issues, starting with Trump's Middle East diplomacy that secured substantial investment deals while shifting focus from human rights to commerce. Trade negotiations with China aim to reduce tariffs and improve market access for American companies, although uncertainties persist about long-term impacts. Fiscal policy is scrutinized as the GOP debates a tax bill extending cuts but risking national debt escalation. Solutions like monetizing federal assets are proposed to address budgetary concerns. Controversies over state bans on cell-based meat highlight economic protectionism versus innovation. Lastly, the executive order targeting pharmaceutical prices raises questions about government intervention and its effects on R&D, emphasizing the need for reform in pricing mechanisms.
00:00
00:00
Trump's Middle East trip aims to strengthen alliances and address regional conflicts.
01:58
01:58
We deeply regret any hurt caused to Phil Hellmuth by our previous statements.
25:25
25:25
Iran quickly capitulated following Trump's Middle East initiatives.
43:41
43:41
While some trade issues seem resolved, remaining tariffs still impact markets.
54:48
54:48
Unsustainable spending driven by gamesmanship in Congress.
1:21:03
1:21:03
If the product is good, it will be adopted.
1:32:39
1:32:39
Cost of drug trials has increased 10x from early 90s to 2025 due to regulations.
